Gunggung dhuwit awis saben saham Natera Medical (NTRA)

Lambang korporat lan logo Natera, Inc. (NTRA)

Natera, Inc. (NTRA) is based on unique genomic data and proprietary DNA analysis. The estimated cash per share demonstrates current liquidity, with the value of 7.63 characterizing this level. Management's aggressive strategy ensures rapid revenue growth, while the focus on in-house R&D and patent protection eliminates the need for mergers with other players.

Natera Inc (NTRA): Dhuwit awis saben siji saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan Natera, Inc.

- rega pasar lan target rega analis:
- rincian kapitalisasi pasar:
- rincian posisi dhuwit lan arus kas:
Ringkesan analisis perusahaan:NTRA Natera, Inc.
Produk asil prodhuksi Natera Inc

This indicator determines the volume of liquid assets per common share, allowing for an assessment of the internal capital cushion and investor protection. Analyzing the average cash per share reveals how explosive demand for Natera, Inc. (NTRA) oncology tests has transitioned the company from depleting reserves to self-funding via positive operating cash flow.